Neuronal activity and amyloid-beta cause tau seeding in the entorhinal cortex in Alzheimer's disease
Alexandersen, C. G. G.; Bassett, D.; Goriely, A.; Chaggar, P.
Show abstract
The entorhinal cortex is the earliest site of tau pathology in both Alzheimers disease and primary age-related tauopathy, yet the mechanisms underlying this selective vulnerability remain poorly understood. Here, we use a computational model integrating neuronal activity and amyloid-{beta} deposition with interneuronal tau transport to predict regional susceptibility to tau seeding. Using fluorodeoxyglucose PET as a measure of neuronal activity, we show that brain-wide activity patterns drive tau accumulation in the medial temporal lobe, independent of amyloid status. Incorporating amyloid PET, we further show that amyloid-{beta} selectively amplifies tau seeding in the entorhinal cortex, aligning with its early involvement in Alzheimers disease. These predictions are supported by cross-subject correlation analysis, which reveals a significant association between model-derived seeding concentrations and empirical tau deposition. Our findings suggest that neuronal activity patterns shape the early landscape of tau pathology, while amyloid-{beta} deposition creates a unique vulnerability in the entorhinal cortex, potentially triggering the pathological cascade that defines Alzheimers disease.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 96%
- Tau-first subtype of Alzheimer's disease consistently identified across in vivo and post mortem studies 95%
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 95%
Similar papers in this journal
- AI-driven fusion of neurological work-up for assessment of biological Alzheimer’s disease 95%
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 95%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 95%
Similar papers in this journal
Similar papers in this journal
- Simulating the outcome of amyloid treatments in Alzheimer's Disease from multi-modal imaging and clinical data 96%
- Whole-brain functional connectivity predicts regional tau PET in preclinical Alzheimer's disease 95%
- Tau pathology mediates the effects of amyloid on neocortical tau propagation and neurodegeneration among non-demented individuals 94%